Skip to Content

Clinical ancillary management expertise helps biopharma company oversee a large, global trial from start through finish.

Follow a biopharmaceutical company entering a Phase III trial that included 45 countries and an enrollment target of 4,000 patients in a randomized, double-blind, placebo-controlled study. 

Learn more about how this company managed to:

  • Source ancillaries across multiple geographic markets
  • Manage logistics across a global footprint
  • Comply with country-specific regulations
  • and more!